
Dargo Bio
达歌生物
Dargo Bio
Biotech/Healthcare
Dage Biotech develops molecular glue-based targeted protein degradation technologies and novel therapeutics. Starting from a new chemical scaffold discovered by Professor Cang Yong's laboratory, the company has built a proprietary compound library distinct from the lenalidomide- and…
Latest round: Series A Extension+ (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-05-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.